Science Explorer Back to mapMap
Discussion
Researcher · University of Nottingham · United Kingdom

Cara Moloney

Cara Moloney publishes mostly in Biomaterials, Molecular Biology and Biomedical Engineering, on topics such as Nanoparticle-Based Drug Delivery, Glioma Diagnosis and Treatment and RNA Interference and Gene Delivery.

ORCID 0000-0002-2230-6612 OpenAlex
World rank
#6,444,869
of 7,710,434 ranked researchers
Rank in United Kingdom
#347,020
of 367,258
Works
42
Citations
290
Citations per work
6.9
h-index
10
i10-index 11Top 71% in Biomaterials
Cara Moloney

What does Cara Moloney research?

Cara Moloney's work is mostly in Materials Science (24%), Biochemistry, Genetics and Molecular Biology (19%), Engineering (15%).

Physical Sciences: 19 works · 45.6% of their workMaterials Science: 10 works · 23.7% of their workBiomaterials: 8 works · 20.2% of their workMaterials Chemistry: 1 works · 3.5% of their workEngineering: 6 works · 14.9% of their workBiomedical Engineering: 6 works · 14.9% of their workChemistry: 3 works · 7.0% of their workOrganic Chemistry: 3 works · 7.0% of their workEverything else: 11 works · 27.2% of their workLife Sciences: 8 works · 19.3% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 19.3% of their workMolecular Biology: 8 works · 19.3% of their workHealth Sciences: 3 works · 7.9% of their workMedicine: 3 works · 7.9% of their workGenetics: 3 works · 7.9% of their workTHEIR WORKCara Moloney42works
Life Sciences19%Physical Sciences46%Health Sciences8%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Materials Science1023.7%
    2. Engineering614.9%
    3. Chemistry37.0%
  2. Everything else1127.2%
    1. Biochemistry, Genetics and Molecular Biology819.3%
    1. Medicine37.9%
  1. 1Biomaterials20% of their works
  2. 2Molecular Biology19% of their works
  3. 3Biomedical Engineering15% of their works
  4. 4Genetics8% of their works
  5. 5Organic Chemistry7% of their works
  6. 6Materials Chemistry4% of their works

Research topics

Which keywords describe Cara Moloney's research?

The keywords of their largest research topics: Biomedical Applications, Nanoparticles, Tumor Targeting, Immunotherapy, Drug Delivery, Nanocarriers, Glioblastoma and Temozolomide.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Biomedical Applications243 topics
  2. Nanoparticles243 topics
  3. Tumor Targeting202 topics
  4. Immunotherapy152 topics
  5. Drug Delivery141 topic
  6. Nanocarriers141 topic
  7. Glioblastoma91 topic
  8. Temozolomide91 topic
  9. Biodegradable Polymers61 topic
  10. Chromatin Remodeling61 topic
  11. Photothermal Therapy61 topic
  12. Polylactic Acid61 topic
  13. RNA Interference61 topic
  14. Reactive Oxygen Species61 topic
  15. SWI/SNF Complexes61 topic
  16. siRNA Delivery61 topic
  17. Click Chemistry41 topic
  18. Ferrofluids41 topic
  19. Living Radical Polymerization41 topic
  20. Magnetic Particle Imaging41 topic

Where does Cara Moloney work?

Cara Moloney's main affiliation in the publication record is University of Nottingham, United Kingdom.

How many publications and citations does Cara Moloney have?

OpenAlex counts 42 works and 290 citations for Cara Moloney, an h-index of 10, ranking #6,444,869 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Cara Moloney. Posts are plain text and can be reported.